Center For Financial Planning, Inc. Astrazeneca PLC Transaction History
Center For Financial Planning, Inc.
- $748 Million
- Q4 2024
A detailed history of Center For Financial Planning, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 1,057 shares of AZN stock, worth $81,462. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,057
Previous 671
57.53%
Holding current value
$81,462
Previous $52,000
32.69%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.65 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.16 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.89 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.85 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.85 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...